Tactile Systems Technology, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Tactile Systems Technology, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $1.03M, a 22.42% increase year-over-year.
- Tactile Systems Technology, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-12-31 was $549.00K, a 10.88% decline year-over-year.
- Tactile Systems Technology, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $0.00.
- Tactile Systems Technology, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $843.00K, a 19.25% decline year-over-year.
- Tactile Systems Technology, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $1.39M, a 16.14% decline from fiscal 2024.
- Tactile Systems Technology, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $1.66M, a 7.72% increase from fiscal 2023.
- Tactile Systems Technology, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $1.54M, a 19.83% increase from fiscal 2022.
- Tactile Systems Technology, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $1.29M, a 44.38% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $1.03M 10-Q · filed 2026-08-10 | |
| 2025-12-31 | $549.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.39M 10-K · filed 2026-02-17 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | |
| 2025-06-30 | $843.00K 10-Q · filed 2026-08-10 | |
| 2024-12-31 | $616.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.66M 10-K · filed 2026-02-17 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | |
| 2024-06-30 | $1.04M 10-Q · filed 2025-08-04 | |
| 2023-12-31 | $659.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.54M 10-K · filed 2026-02-17 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | |
| 2023-06-30 | $882.00K 10-Q · filed 2024-08-05 | |
| 2022-12-31 | $462.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $1.29M 10-K · filed 2025-02-18 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | |
| 2022-06-30 | $824.00K 10-Q · filed 2023-08-07 | |
| 2021-12-31 | $770.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $2.31M 10-K · filed 2024-02-20 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | |
| 2021-06-30 | $1.54M 10-Q · filed 2022-08-01 | |
| 2020-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $2.90M 10-K · filed 2023-02-21 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | |
| 2020-06-30 | $1.82M 10-Q · filed 2021-08-02 | |
| 2019-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $3.05M 10-K · filed 2022-02-23 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | |
| 2019-06-30 | $1.85M 10-Q · filed 2020-08-03 | |
| 2018-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $2.71M 10-K · filed 2020-02-26 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | |
| 2017-12-31 | $927.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $3.14M 10-K · filed 2020-02-26 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B |